1. 綠咖啡豆提取物green coffee bean extract

綠咖啡豆提取物

品名:綠咖啡豆提取物

拉丁名:Coffea robusta or Coffea arabica

有效成分:綠原酸/總綠原酸

顏色:淺棕色至淺黃色粉末

提取部位:咖啡豆

含量:50%,60%,75%

檢測部位:HPLC

綠咖啡豆提取物來源於茜草科植物小果咖啡、中果咖啡及大果咖啡的種子。其主要成分為綠原酸，具有降壓、抗腫瘤、補腎、抗氧化等作用，也可用作保健食品中，使保健食品香甜可口味道

 

綠咖啡豆的功效：

1.減肥作用：綠咖啡中的綠原酸達到一定濃度時，能推動人體分解體內脂肪以補充能量，以達到減脂效果。

2.降壓作用：綠原酸有明顯的降壓作用，而其療效平穩、無毒副作用；

3.抗腫瘤作用:具有顯著的預防和治療鼻咽癌的功效，具有顯著的治療腫瘤的功效，並具有低毒、安全的特點，日本學者研究綠原酸有抗變異的作用，揭示了對腫瘤的預防作用；

4.補腎、增強機體免疫作用

5.抗氧化、抗衰老、抗拒如骨骼老化

6.抗菌、抗病毒，利尿、利膽、降血脂、保胎的作用

7.保健食品:可使保健食品香甜可口味道好，具備清熱解毒、養顏潤膚、解除煙酒過多等特點。

 

參考文獻：

  1. 1. 

    Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C: The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr. 2003, 133: 3228-3232. 

  2. 2. 

    Rasch V: Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand. 2003, 82: 182-188. 10.1034/j.1600-0412.2003.00078.x.

     
  3. 3. 

    Virtanen SM, Rasanen L, Aro A, Ylonen K, Lounamaa R, Akerblom HK, Tuomilehto J: Is children's or parents' coffee or tea consumption associated with the risk for type 1 diabetes mellitus in children? Childhood Diabetes in Finland Study Group. Eur J Clin Nutr. 1994, 48: 279-285.

  4. 4. 

    Van Dam RM, Feskens EJ: Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002, 360: 1477-1478. 10.1016/S0140-6736(02)11436-X.

  5. 5. 

    Fredholm BB, Lindgren E: The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. Acta Pharmacol Toxicol. 1984, 54: 64-71.

  6. 6. 

    Arciero PJ, Gardner AW, Calles-Escandon J, Benowitz NL, Poehlman ET: Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol. 1995, 268: E1192-1198.

  7. 7. 

    Ryan DH: Medicating the obese patient. Endocrinol Metab Clin North Am. 1996, 25: 989-1004. 10.1016/S0889-8529(05)70366-2.

  8. 8.De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ: Immunohistochemical identification of the β3-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with and caffeine. Int J Obes Relat Metab Disord. 2002, 26: 1442-1450. 10.1038/sj.ijo.0802148. 

  9. 9. 

    Greer F, Hudson R, Ross R, Graham T: Caffeine ingestion decrease glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes. 2001, 50: 2349-2354. 

  10. 10. 

    Ryu S, Choi SK, Joung SS, Suh H, Cha YS, Lee S, Lim K: Caffeine as a lipolytic food component increases endurance performance in rats and athletes. J Nutr Sci Vitaminol. 2001, 47: 139-146.

  11. 11. 

    Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, Below P, Herling AW: Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys. 1997, 339: 315-322. 10.1006/abbi.1996.9874.

  12. 12. 

    Del Castillo MD, Ames JM, Gordon MH: Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem. 2002, 50: 3698-3703. 10.1021/jf011702q. 

  13. 13. 

    Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I: Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res. 2002, 25: 99-107. 10.1291/hypres.25.99. 

  14. 14. 

    Iwai K, Kishimoto N, Kakino Y, Mochida K, Fujita T: In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. J Agric Food Chem. 2004, 52: 4893-4898. 10.1021/jf040048m.

  15. 15. 

    Shimoda H, Ninomiya K, Nishida N, Yoshino T, Morikawa T, Matsuda H, Yoshikawa M: Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg Med Chem Lett. 2003, 13: 223-228. 10.1016/S0960-894X(02)00889-2.

  16. 16. 

    Markwell MAK, MacGroarty EJ, Bieber LL, Tolbert NE: The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J Biol Chem. 1973, 248: 3426-3432.

  17. 17. 

    Rodriguez de Sotillo DV, Hadley M: Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem. 2002, 13: 717-726. 10.1016/S0955-2863(02)00231-0.

  18. 18. 

    Zheng G, Sayama K, Okubo T, Juneja LR, Oguni I: Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo. 2004, 18: 55-62.

  19. 19. 

    Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, Dahlmans VEH, Havekes LM, Stellaard F, Katan MB, Princen HMG: Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Arterioscler Thromb Vasc Biol. 2000, 20: 1551-1556.

  20. 20. 

    Boekema PJ, Samsom M, van Berge Henegouwen GP, Smout AJ: Coffee and gastrointestinal function: facts and fiction. Scand J Gastroenterol Suppl. 1999, 230: 35-39.

  21. 21. 

    Ide T: Effect of dietary α-linolenic acid on the activity and gene expression of hepatic fatty acid oxidation enzymes. Biofactors. 2000, 13: 9-14.

  22. 22. 

    Ide T: Nutritional regulation of hepatic fatty acid oxidation and synthesis. J Jpn Soc Nutr Food Sci (in Japanese). 2002, 55: 105-110.

回到頂部
桌面版